Categories
- All
- Animal & Veterinary
- Award
- Biologics
- Coronavirus
- Cosmetics
- Design
- Dietary Supplements
- Drugs
- Follow @FDAmedia on Twitter
- Follow @FDAMedia on X
- Follow @US_FDA on Twitter
- Follow @US_FDA on X
- Follow FDA on Facebook
- Food & Beverages
- Healthy
- Hotel
- Infant Formula & Foods
- Infectious Disease
- Lifestyle
- Medical Devices
- Nature
- Office
- Over-the-Counter Drugs
- Tobacco
- Training
- Travel Tips
- Travel Tips
- Vaccines
Filter Articles
Search by title or filter by category
911 articles found
-
FDA Takes Important Steps to Increase Racial and Ethnic Diversity in Clinical TrialsToday, the U.S. Food and Drug Administration issued a new draft guidance to industry for developing plans to enroll more participants from underrepresented racial and ethnic populations in the U.S. i... -
FDA Roundup: April 12, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On April 8, the FDA cleared Fitbit’s Irregular Rhythm Notifications software intended to...
-
FDA and DEA Warn Online Pharmacies Illegally Selling Adderall to ConsumersThe U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration recently issued joint warning letters to operators of two websites illegally selling Schedule II stimulants, includin...
-
FDA Roundup: April 8, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On April 7, the FDA authorized an extension for the shelf life of the refrigerated Janss...
-
Joint Statement from CMS Administrator Chiquita Brooks-LaSure and FDA Commissioner Robert M. Califf, M.D., on Ensuring Access to Safe and Effective TreatmentsEnsuring the availability of innovative interventions for people is a shared priority for both the Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA). We re...
-
FDA Roundup: April 5, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA announced sotrovimab is no longer authorized to treat COVID-19 in any U.S...
-
FDA Roundup: April 1, 2022Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published the FDA Voices: “Give Your Community a Boost: Combatting Misinf...
-
Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised IndividualsToday, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals....
-
FDA Seeks $8.4 Billion to Further Investments in Critical Public Health Modernization, Core Food and Medical Product Safety ProgramsToday, the U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President’s fiscal year (FY) 2023 budget – a nearly 34% ($2.1 billion) increase ov...
-
Federal judge enters consent decree against New Jersey raw animal food manufacturerThe U.S. Food and Drug Administration (FDA) announced today that Bravo Packing, Inc., an animal food manufacturing company of Carney’s Point, New Jersey, has agreed to stop selling, manufacturing and...